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Abstract 
Whole-genome sequencing in an isolated population with few founders directly ascertains variants from the 
population bottleneck that may be rare elsewhere. In such populations, shared haplotypes allow imputation of 
variants in unsequenced samples without resorting to statistical methods, as in studies of outbred cohorts. We 
focus on an isolated population cohort from the Pacific Island of Kosrae, Micronesia, where we previously 
collected SNP array and rich phenotype data for the majority of the population. We report identification of long 
regions with haplotypes co-inherited between pairs of individuals and methodology to leverage such shared 
genetic content for imputation. Our estimates show that sequencing as few as 40 personal genomes allows for 
imputation in up to 60% of the 3,000-person cohort at the average locus. We ascertained a pilot data-set of 
whole-genome sequences from seven Kosraean individuals, with average 5X coverage. This dataset identified 
5,735,306 unique sites of which 1,212,831 were previously unknown. Additionally, these Kosraen variants are 
unusually enriched for alleles that are rare in other populations when compared to geographic neighbors. We 
were able to use the presence of shared haplotypes between the seven individuals to estimate imputation 
accuracy of known and novel variants and achieved levels of 99.6% and 97.3%, respectively. This study presents 
the first whole-genome analysis of a homogenous isolate population with emphasis on rare variant inference. 
Introduction 
Founder populations play significant roles in population genetics and trait mapping due to the effects of 
bottlenecks and drift on their genetic variation[1]. Such populations are singularly useful in identifying rare 
disease variants that often appear in the isolated cohort at a higher frequency or within a more clearly 
discernable haplotype structure[2] than in out-bred populations. Additionally, identified variants are still 
valuable beyond the isolated group as their effect replicates in more outbred populations[3,4] and can 
implicate new functionally important genes. Next generation sequencing of personal genomes has revealed a 
multitude of rare variants. Presently, high-quality personal genomes exist from representatives of the major 
continental groups[5,6,7,8,9,10,11], but only genotyping and lower-throughput sequencing data is available 
for isolated populations[12,13]. This paper reports low-pass whole-genome sequencing and analysis of seven 
individuals from an isolated Pacific population, chosen specifically for the insight they might provide into the 
larger cohort as well as the presence and functional importance of rare variants they carry. 
The cost of whole-genome sequencing is not trivial and the best strategy for identification of rare causative 
variants must balance the number of genomes sequenced with the insights gained that are applicable to 
different populations and multiple traits. For common traits, one may sequence a reference panel to 
statistically impute variants in populations represented by such a panel[14]. However, this requires 
sequencing high numbers of genomes and is still severely underpowered in populations or variants that are 
underrepresented in such datasets (e.g. isolated populations[15] and rare variants[16]). For Mendelian 
diseases a successful strategy has been whole-exome capture in a small number of individuals[17,18]. 
However, such studies are limited to extremely penetrant phenotypes, inherently ignore non-coding regions, 
and do not yet scale to population-based analysis[19]. Another alternative strategy has been targeted re-
sequencing of candidate loci detected in a GWAS across many individuals. Nevertheless, pursuing such a 
strategy genome-wide is still resource intensive despite a considerable drop in sequencing costs, and scales 
poorly for multiple traits across a large number of loci in each. 
We set out to leverage the opportunities and address the challenges of sequencing-based mapping in a multi-
trait GWAS cohort from an isolated population. Ongoing work by large sequencing consortia, such as the 1,000 
Genomes Project[20,21], has shown that analyzing multiple individuals, even at low coverage, improves 
quality and completeness of detecting and calling novel variants. Moreover, information from a small sub-
sample of sequenced individuals combined with relatively inexpensively acquired SNP array platforms can be 
used to impute much of the missing variation with high accuracy[14,22]. In the current study we used this 
knowledge to develop a sequencing-based framework that leverages the inherent potential of a sizeable 
phenotyped cohort with a small founder population. We applied it to the Kosraen data set in which we 
previously found an abundance of long stretches of the genome identical by descent even between reportedly 
unrelated pairs of individuals[23].  
We shot-gun sequenced a pilot group of seven individuals and performed multi-sample calling and imputation 
to quantify the informativeness of this cohort. The detected variants were validated and compared with those 
observed in other published whole-genome sequencing efforts from different populations. Internally, we 
analyzed the distribution of all variation as well as individual functional classes. Lastly, we estimated the 
effectiveness of IBD segments detected from SNPs in predicting the underlying untyped variants. 
Results 
We have been studying genetic determinants for a multitude of traits in a cohort of 2,906 individuals (the 
majority of adults) from the Micronesian island of Kosrae. This cohort has been previously genotyped on the 
Affymetrix 500k SNP array platform, reporting positive GWAS results for seven phenotypes (including details 
on the screening and genotyping process[24], and statistical analysis of traits within the population[4]). 
Subsequently, we reported a GWAS in which 27 traits were analyzed under family-based models[25] and 
quantified the abundance of IBD segments within the cohort[23]. 
We utilized the autosomal SNP genotype data to estimate pervasiveness of IBD in genomic regions between 
arbitrary pairs of samples, and as a consequence, the potential for IBD-based imputation in this population. 
Regions of IBD were recovered using GERMLINE, a tool for efficient whole-genome IBD detection from 
partially phased data[23] (Materials & Methods). For the purpose of imputation, we conservatively examined 
only IBD segments longer than 5cM, where GERMLINE has been demonstrated to have 100% specificity in 
simulation[23,26]. We found that for an average individual, such regions span a total of 10.8% of all genotypes 
in the remaining cohort. We then seek to estimate the utility of these IBD segments for imputing genomic data 
within the population from a sequenced subgroup.  We first make a simplifying assumption to trust all of the 
detected IBD regions and ignore subsequent potential sequence error or variant differences. In other words, 
we presume that a sequenced individual can infer all information in IBD regions it shares with other un-
sequenced samples, which yields an upper-bound estimate of imputation capacity. We developed a novel 
method for optimizing the selection of highly representative individuals to sequence and quantifying the 
amount of data that can be inferred from their genomes. Briefly, the method uses a special-purpose data 
structure, an interval tree, to find the individual with highest totality of IBD sharing on both homologous 
copies of the genome; isolate that individual into the sequence panel; and, after excluding all of their shared 
segments, continue the calculation in an iterative manner (Figure 1A). This method, INFOSTIP 
(http://www.cs.columbia.edu/~itsik/Software.htm) is discussed in greater detail and evaluated in 
Supplementary Methods. Figure 1B presents the results of this analysis, an estimate of the fraction of the 
genotyped sample cohort that can be inferred as a function of the sequencing budget (number of sequenced 
individuals). We observe that sequencing 50 randomly chosen individuals (1.7% of cohort) would give us the 
potential to impute both alleles of variants in 59.5% of the cohort genome, but choosing individuals in an 
optimized fashion using INFOSTIP decreases the sequenced sample size needed for the same benchmark by 
24% to 38 individuals (1.3% of cohort). Remarkably, sequencing only seven individuals (0.24% of cohort) still 
provides imputation capacity of 24% of the cohort genome. For comparison, we conducted the same analysis 
within a cohort of 1,200 Ashkenazi individuals[27], a population known to be isolated but less densely related. 
In this case we found that utilizing our optimal selection method and sequencing 38 individuals gave us the 
potential to impute variants in only 16% of the cohort genome, whereas sequencing seven individuals allowed 
us to infer only 4% of the cohort genome (see Figure 1B, Supplementary Figure 1 and Materials & Methods for 
additional analysis). This type of imputation is agnostic of allele frequency as long as a relevant IBD segment is 
available. 
Sequencing benchmarks 
We sequenced a discovery panel of seven low-pass personal genomes, four of which were selected according 
to the aforementioned procedure with the remainder chosen according to phenotype (Materials & Methods). 
For each of the seven individuals, 10-30 micrograms of genomic DNA was used to generate a library following 
Life Technologies’ long mate-pair protocol. The libraries were sequenced using the SOLiDTM System, with 
8,239,389,322 raw 50 bp mate-paired reads and an additional 740,209,937 raw 35 bp mate-paired reads, 
generating a total of 438 Gb. The raw reads were aligned and paired to the reference human genome (hg18) 
using the AB SOLiD Corona Lite pipeline (http://solidsoftwaretools.com).  Up to 3 mismatches were allowed 
for 35 bp reads and up to 5 mismatches were allowed for 50 bp reads.  This generated 158 Gb that map to the 
genome as uniquely placed normal mate pairs within the expected distance (1.5 kb insert size), order and 
orientation. 96.6 Gb of these uniquely placed normal mates are non-redundant, which represents a >30X 
coverage of the “Kosraen genome”. On average, 3-6X sequence coverage of non-redundant normal uniquely 
placed pairs was achieved for each individual (Supplementary Table 1). 
Variant calling 
Following the structure of the 1,000 Genomes Project low-pass pilot, we performed variant calling on all seven 
samples together using the Genome Analysis Toolkit[28] as well as several steps of imputation. In summary, 
we performed local realignment and quality score recalibration of the reads from each individual separately; 
variants in all samples were then called together using an iterative Bayesian algorithm that attempts to infer 
allele frequency in the population in support of individual genotype calls; for previously known variants, we 
used a strict call quality threshold to minimize false-positives; for novel variants, we performed an additional 
variant quality score recalibration procedure to minimize expected false-positives; lastly, we performed 
internal imputation using the BEAGLE framework[29] and external imputation to the 1,000 Genomes pilot 
haplotypes using MaCH[22]. This strategy allows us to leverage the presence of a confidently observed variant 
in higher-coverage samples to recover calls in lower-coverage samples that would not have been called 
individually. The detailed variant calling protocol is described in full in the Materials & Methods. 
We performed rigorous quality control on the set of called variants using the available array-based genotypes 
and additional novel genotyping as validation data (Table 1). Of the previously known sequence calls, 
2,958,772 overlapped with the genotyped variants and were used for validation, allowing evaluation of 
specificity of detecting non-reference sites, as well as of calling each genotype class. We measured the 
specificity of calling SNPs from all seven samples together on non-reference calls at these known sites to be 
98.2%. We independently computed similar levels of specificity, 98.9%, that would be expected based on the 
observed transition/transversion ratio of 2.07 across all of the previously known variant sites (see Materials & 
Methods). Per-call specificity of SNP calling from the samples together varied by sample, with an average of 
94.1% for heterozygous calls and 92.5% for homozygous calls (Supplementary Table 2). Low coverage often 
caused heterozygous SNPs to be identified as homozygous. The low coverage from this pilot, our strict quality 
thresholds and the pooling of all seven samples led to a sensitivity to detect non-reference sites of 92.8%. For 
variants that were not previously known, we observed an overall transition/transversion ratio of 1.74, 
corresponding to expected specificity of 88.9%. We validated a total of 64 called novel sites using Sequenom 
genotyping (Materials & Methods, Supplementary Table 3) and found the empirical specificity of non-
reference calls to be 87.5%, in-line with our overall estimates. Additionally, we detailed the array-based 
validation results at each step of the calling pipeline and found the largest increase in accuracy to come from 
calling all samples together rather than individually and from internal imputation (Supplementary Table 2) as 
previously reported [21,30,31]. 
Variation discovered 
We now focus specifically on variants identified in the autosomes, as these are directly applicable to our IBD-
based analysis. Our final set of SNVs contained 22,221,159 non-reference calls across all seven discovery 
samples for a total 5,735,305 unique sites of which 1,212,831 (21%) were previously unknown (not in dbSNP 
v130). The total number of non-reference calls ranges across individual samples from 3.1 to 3.4 million 
(Supplementary Table 4). We expect this to be an incomplete estimate, representing the limitation of low-pass 
sequencing in calling variants at low-coverage sites due to undersampling of the variant allele. For a fair 
comparison to other genomes, we extrapolate the total number of variants in the mappable genome based on 
the error rates described in the previous section (see Materials & Methods). Thus, we estimate an average 
Kosraen sample to contain 3,241,030 total autosomal variants ( 66,996 s.d.). Comparing the genomewide 
estimates to a variety of published genome sequences (Supplementary Figure 2), we find the overall number 
of variants is nearly identical to the 3.25 million observed in average East Asian autosomes[5,7,10]. Comparing 
the called variants to markers previously annotated in dbSNP v130, we estimate 10.2% (0.90% s.d.) of the 
variants in the average Kosraen to be novel, not significantly different from the 9.4% average (3.5% s.d.) in 
other East Asian samples[5,7,10]. Due to the long history of isolation in this cohort we suspect many of the 
observed novel variants to be mutations private to the island. 
Within an average Kosraen sequence, we find 50.7% of non-reference sites to be homozygous ( 2.2% s.d.). 
We caution that this figure is likely to reflect under-called heterozygotes and expected to drop with deeper 
sequencing[11]. However, it is significantly higher than the observed homozygosity rate in the other personal 
genomes, even those with similar coverage (next highest - 41.7% in Anonymous Asian[10]). Historically, the 
population experienced a series of severe bottlenecks, which would have resulted in many variants drifting to 
higher frequency and becoming homozygous. 
We estimate the unique novel variation that each sequenced individual contributed by averaging over all 
5,040 permutations of the seven samples (Supplementary Figure 3). We find that the first Kosraen sample to 
be considered contributes approximately a third of the novel sites that were called in all samples (352,162 of 
1,014,310; Supplementary Table 5), with decreasing contribution of subsequent samples. This decrease, 
initially by 40% of novel variants that are overlapping between an average pair of samples, becomes more 
gentle for additional samples, reflecting the enrichment of rare variants in this set, eventually reaching 
approximately 50,000 variants contributed by the last sample only - the average number of single-carrier 
variants.  
Analysis across sequenced populations  
We analyzed the population specificity of the Kosrean variants by examining their respective allele frequency 
in the reference populations sequenced as part of 1,000 Genomes Pilot I. Within each of the pilot cohorts of 
Yoruban (YRI), European (CEU), and East Asian (JPTCHB) origin, we measured the allele frequency of 
homozygous variants from the Kosraen (KOS), Korean (SJK), European (JCV), and Yoruban (YRI) sequenced 
genomes. The proportion of variants that fall into each allele frequency window of a reference cohort is 
shown in Figure 2. Focusing on the differences between the Kosrean and their closest analyzed neighbor - the 
SJK Korean genome - we observe that the average Kosrean is relatively enriched for rare variants in all three 
populations. Specifically, the percentage of alleles in an average Kosraen that were uncommon in JPTCHB 
(below 10% frequency) was 4.4-fold higher than that of SJK (Figure 2A). In the other cohorts, we see more 
subtle but consistent enrichment of 1.42-fold and 1.24-fold in uncommon CEU and YRI alleles respectively 
(Figure 2B,C). This trend suggests that lower frequency alleles in other populations that are present in Kosrae 
have drifted to higher frequency within the cohort as compared to the Korean genome. 
Analysis within the isolate population  
We annotated the called variants according to their functionality and analyzed the carrier frequencies of sites 
that have coding or splicing implications. From the overall frequency distributions (Supplementary Figure 4), 
we observe a significant increase in novel coding variants appearing as either singletons or fixed non-reference 
alleles when compared to novel non-coding variants (P=8.7 x 10-10 from χ2 test). Focusing on specific coding 
sub-classes in Figure 3, we examine variants called in all samples and annotated as: (A) splice junction, all 
coding, synonymous, missense and nonsense; as well as (B) showing all known and novel variants (full data in 
Supplementary Table 5, Supplementary Figure 4). As reported in previous studies [17,32,33], we see significant 
over-abundance of singleton nonsense mutations compared to other singleton variant classes (P=5.4 x 10-4 or 
1.4 x 10-4 compared, respectively, to coding or all variants). This over-abundance is consistent with the effects 
of purifying selection negatively affecting the frequency of functionally important variants. All of the detected 
non-synonymous mutations were significantly enriched for genes with the gene ontology term ‘olfactory 
receptor activity’ (P=4.4 x 10-7 after Bonferroni correction[34]; increased enrichment when compared to 
synonymous mutations), evidence of a continued process of pseudogenization in this family. 
Structural variation 
We identified short insertions and deletions using the Dindel algorithm[35] in all samples together. Briefly, 
Dindel identifies candidate indels within the read data and then attempts to align them to haplotypes that 
represent alternative sequences to the reference (detailed protocol in Materials & Methods). Supplementary 
Figure 5 details the distribution of novel and previously known indels across the seven sequenced individuals. 
Overall, we observe a steep decrease of indel carrier rate, with 46% of all indels present in a single individual. 
As with SNVs, the novel indels tend to be enriched for singleton and fixed indels in this cohort when compared 
to previously known sites. 
We identified structural variants longer than 10kb using the SOLiD Software Tools, which combines depth-
coverage, predicted mappability, and GC-content, within a Hidden Markov Model framework to make CNV 
region calls. Overall, an average individual contained 77.1MB of copy-variable regions end-to-end, with the 
longest variant being a 7.6MB heterozygous deletion on chromosome 19p13. We analyzed the lengths of the 
CNVs found in all the samples by variant type and length (Supplementary Figure 6). In particular, CNVs of size 
less than 100 kb constitute 66.9% of the calls, with most being heterozygous deletions. We also looked at the 
number of shared and private CNVs among the Kosraen individuals, with a CNV being considered shared 
between two individuals if the overlap between the two called regions was at least 80%. For an average 
individual, approximately 20% of CNVs are shared by the entire population. 
IBD analysis 
Assessing the IBD-based motivation for this pilot, we focused on the 1,522 shared segments predicted 
between the sequenced individuals, ranging in length from 330kb to 74Mb. Unlike the conservative INFOSTIP 
analysis, which examined fewer but higher-quality IBD segments, these segments were detected using 
GERMLINE’s default parameters with no adjustment (3cM segment length minimum), allowing us to estimate 
IBD accuracy under practical conditions. We evaluated the accuracy and utility of the IBD-based approach by 
examining variant concordance within these regions. Specifically, two samples that are IBD across a region 
should not have sites with homozygous calls for opposite alleles in that region. For a pair of such samples, we 
examine all sites in the IBD region that are mutually homozygous with at least one sample being non-
reference, and report concordance as the percentage of these sites that are not homozygous for opposite 
alleles. Lack of such concordance is indicative of either falsely called IBD or poor genotype calls due to under-
sampling of sequence reads (true heterozygous sites miscalled as homozygous). Aside from some effects on 
multi-sample calling, the concordance rate can be treated as a measure of baseline homozygous variant 
imputation accuracy when one of the individuals had not been sequenced. Figure 4 shows concordance across 
IBD segments, separated into previously known (A) and novel (B) variants. For comparison, we measured the 
background distribution such concordance across 30 random selections of same-sized regions, shown in black 
points. We observe the vast majority of IBD segments having nearly 100% concordance, with only 1.4% and 
10.6% of segments below 90% concordance for known and novel variants, respectively. If we take a weighted 
average across all segments, the aggregate concordance is 99.6% (known) and 97.3% (novel) in IBD-segments, 
providing encouraging estimates for accuracy of IBD-based imputation. This is compared to a background 
concordance statistic averaging 82.9% (known) and 31.0% (novel) in permuted segments. We attribute the 
difference between known and novel concordance in IBD regions to be an artifact of lower sensitivity to novel 
variants and the overall deviation from full concordance to be indicative of inaccurate detection of IBD regions 
or their exact boundaries. 
Of particular interest to the IBD community is the minimum length at which stretches of SNPs identical by 
state (IBS) are still predictive of identity at un-typed variants[36]. To estimate this, we omit the minimum 
segment length restriction for IBD detection, resulting in a tally of all runs of at least 128 IBS SNP-array sites in 
the sequenced samples, rather than the set of putative IBD regions we considered thus far. We measured 
concordance in length windows of 1cM from 0-10cM and above. Supplementary Figure 7 shows this 
concordance distribution for known and novel variants, as well as the number of segments measured within 
each window. As previously documented[23], we see a direct correlation of concordance with segment length,  
as longer IBS segments are more likely to represent true recent IBD. However, we observe only a slow 
decrease in concordance from high-quality 10cM segments down to 2-3cM indicating either a small number of 
false-positive segments or overcalled false IBD primarily around the boundaries of true IBD segments.  Even 
within the 0-1cM length window (median physical length 815kb) we see 98.9% (known) and 91.6% (novel) 
concordance, significantly above the average in non-IBD regions. These initial findings suggest that even very 
short IBS segments can be useful for variant inference. 
Discussion 
While the population genetics of isolated groups has been of interest for decades, the contribution of such 
groups to understanding heritable traits is strongly dependent on the research methodology employed. In the 
context of inbred populations, linkage analysis of Mendelian traits using microsatellite scans has mapped 
many mutations that are rare in the general population. In contrast, association analysis with SNP arrays relies 
on linkage disequilibrium in populations, and by primarily targeting common, ancient variation has been 
mainly applied to outbred peoples. High-throughput sequencing now makes possible discovery of rare variants 
in the general population but, as shown in this paper, with the proper strategy can be applied to the study of 
isolated communities efficiently and to great effect.  
Different strategies for high throughput sequencing offer various tradeoffs of investment and potential for 
discovery. Whole-genome sequencing at high coverage is the gold standard, but is still expensive to pursue 
with substantial sample sizes. Focusing on a captured target, either around a genomic area of interest[37] or 
considering all exonic regions[38] sacrifices potential information from most of the genome for high quality 
data regarding the most promising parts. Low pass sequencing offers a different tradeoff, considering the 
entire genome, but accepting lower-quality data. Indeed, the first reference and multiple personal 
genomes[8,11,39] are all low-pass, with meaningful insights regarding technology[40], population 
genetics[41], and mutation detection[17,42]. This work follows suit and provides population-based sequencing 
of Pacific Islanders. 
With an emphasis on accurate variant detection, we ascertained the effectiveness of low-pass sequencing in 
conjunction with multi-sample calling, achieving overall non-reference specificity and sensitivity above 90%. In 
particular, some of the lower-coverage samples netted 2-3 fold increases in accuracy when compared to 
independent calling. Overall, this strategy allowed us to uncover 1,212,831 previously unknown variants with 
high specificity. 
Examining the spectrum of variation, we explored characteristics unique to this cohort, which had undergone 
a series of severe bottleneck events. As expected from such an extreme founder population, the qualitative 
variant statistics reveal an abundance of novel variation and overall homzoygosity. Moreover, those sites that 
have been observed in other sequenced populations still exhibit enrichment for alleles that are rare outside of 
Kosrae. Demonstrating the effects of purifying selection, we observe a significant abundance of rare coding 
variants and singleton nonsense mutations compared to all variants and synonymous mutations, respectively.  
Leveraging the wealth of relatedness and haplotype sharing in the population, we find 97.3% concordance of 
novel variants within segments shared IBD by the sequenced samples, demonstrating the potential for 
inferring such variants in other un-typed but IBD individuals. With a high rate of concordance even in very 
short putative IBD segments, we expect a full panel of 40 sequenced individuals to infer at least 60% of the 
overall population genome. 
Our work highlights the manageability of population sequencing for isolated populations. While infrastructure 
efforts by large consortia such as the 1000 genomes lay foundations for comprehensive catalogs of variants in 
outbred populations, we demonstrate sequencing at the scale of an individual lab as a means to make genetics 
of such populations fully tractable.  
As sequencing studies expand geographically to capture the bulk of common variation, isolated populations 
can help broaden our understanding of rare alleles. While this effort sequenced only a handful of individuals 
and the sequence coverage of each of them is low, their relation to one another and with many other 
islanders facilitates both reliable variant calling as well as powered association analysis to variants detected by 
full sequencing. This approach avoids the ascertainment bias of previous SNP-based studies, and suggests a 
strategy to leverage SNP array data in large samples, where sequencing is still expensive. 
Materials & Methods 
Sample selection 
Four of the samples (K1955, K2033, K5866, K1674) were selected using the INFOSTIP strategy to maximize 
their IBD-based inference capacity to the rest of the 2,906 genotyped individuals from the Kosraen cohort. The 
remaining three samples (K6169, K6494, K5675) were selected based on being phenotypic extremes for 
several metabolic traits, and as carriers of haplotypes associated with these traits (not shown). 
IBD segment analysis and imputation  
The pedigree of 2,906 Kosraen individuals was divided into three groups without replacement: two parents 
and a single child (trio), a single parent and a single child (duo), and single samples (unrelated). Using the 
BEAGLE framework[29], the individuals were phased and missing data inferred taking into consideration their 
respective group structure. The phased genotype data was processed with GERMLINE under default 
parameters and with genetic distance annotation data corresponding to the Affymetrix 500k chip to generate 
the genotype-based IBD shared segments. The same data was additionally processed with GERMLINE under 
the phase-specific haplotype-extension parameters, which explicitly treats each homolog separately in 
generating matches. 
The INFOSTIP analysis was performed on both genotype and haplotype oriented IBD segments. For haplotype 
data, INFOSTIP executed upon each homolog as if it were an independent set of shared segments, but in 
choosing a sample for the sequence panel excluded all of the matches originating from that individual on 
either homolog. As such, a site must be either autozygous, or contained within an IBD segment of two 
differing sequenced individuals to be fully inferred. For genotype data, INFOSTIP ran with no modification and 
hence, a site is considered fully inferred if either homolog is in IBD with a sequenced individual. Because the 
imputed regions were SNP-chip oriented, the total cohort genome length was calculated as the individual end-
to-end length of the genome that contained SNPs, multiplied by the number of samples (for genotype data) or 
twice the number of samples (for haplotype data). Supplementary Figure 1 shows a comparison of the two 
inference techniques (haplotype, genotype) as well as the two selection methodologies (greedy, random). Due 
to the non-negligible presence of some autozygosity within the cohort, these two distributions represent an 
upper and lower bound on the imputation capacity. 
Combined SNV calling 
We followed the protocol for best practice variant detection detailed in the GATK v2 documentation, with 
individual parameters tuned for low-pass data. The specific analysis steps are as follows: 
1. Reads from all lanes for each sample were merged and duplicate molecules flagged. 
2. For each sample, reads were locally realigned around small suspicious intervals (generally indels). For 
single nucleotide variants, dbSNP v130 and the SOLiD single-sample calling were used; for indels, 
dbSNP v130 and 1000 Genomes Project Pilot (07/2010) calls were used. Finally, mate pair reads were 
synchronized. 
3. For each sample, base quality scores were recalibrated using per-base covariates: machine cycle for 
base; di-nucleotide combination for base; number of consecutive previous bases matching this base 
(accounting for homopolymers); position of the base in the read; the primer round for this base (SOLiD 
specific). 
4. All samples were called together using the UnifiedGenotyper module, which uses an iterative Bayesian 
likelihood model to estimate allele frequency in the population and genotype calls. We allowed an 
emitted quality value of 10 and a minimum quality value of 30 for confident calls. Similarly, indels 
supported by at least 2 reads and at least 60% of all reads were also called for the purpose of masking. 
Any calls that were low confidence, overlapped a detected indel, or consisted of 3 or more SNVs within 
10bp were excluded at this stage. 
5. To assess novel variants as accurately as possible, we performed variant quality score re-calibration in 
three stages. We isolated variants at sites that were expected to be known using the HapMap calls 
(release 27), 1000 Genomes Project Pilot low-coverage calls (07/2010), and dbSNP (v129, downgraded 
to minimize new, poorer quality SNPs). We identified clusters within these calls based on quality, allelic 
balance, strand-bias, and homopolymer run. We then classified all variants according to their expected 
False Discovery Rate (FDR) given the established cluster boundaries and kept only those novel variants 
that had expected FDR below 20%. 
6. Finally, we performed imputation of un-typed variants in two stages. First, we imputed variants within 
the cohort using the BEAGLE framework and incorporated any sites with a minimum r2 cutoff of 0.50. 
Next, we imputed variants from the 1,000 Genomes (07/2010) haplotypes using MaCH. Processing 
each chromosome separately, we estimated model parameters from all seven samples and then used 
these estimates to perform a greedy imputation with default parameters, keeping any previously un-
typed sites with a minimum r2 cutoff of 0.50. 
Our final set of calls consisted of high-specificity/low-sensitivity novel variants and aggressively called and 
imputed known variants. Variants not observed in dbSNP v130 were annotated as novel. 
Combined InDel calling 
Indels were called using the Dindel v1.01, a program for calling small indels from short-read sequence data. 
While Dindel does not yet explicitly model multiple independently sequenced samples, we performed the 
analysis in several rounds and shared the reference information across all samples. As per the user manual, we 
first generated a list of candidate indels and mate-pair distance distributions for each sample separately using 
the GATK realigned and recalibrated reads. We then pooled all of the candidate indels into a single reference 
library and mapped each individual against the pooled library to identify the final set of indels. We classified 
indels as previously known if they overlapped with any insertion/deletion site in dbSNP v130. 
Variant extrapolation 
We perform error estimates and variant extrapolation independently for each sample as well as separately for 
known and novel variants in accordance with the following protocol: 
 For previously known variants we measure specificity and sensitivity based on the set of calls 
overlapping with the genotype array, taken as ground truth. Sensitivity is measured as the percentage 
of non-reference genotype sites that are called as non-reference in the sequence; specificity is 
measured as the percentage sequence sites called non-reference that are also called non-reference by 
the array. 
 For novel variants, accurately measuring sensitivity is particularly difficult in low-pass data, and so we 
conservatively assume sensitivity to be the same as for known variants. For measuring specificity, we 
assume that the totality of calls is a mixture of true-positive variants with an expected transition bias 
and false-positive variants occurring randomly and exhibiting no transition bias[11]. Formally, given an 
expected transition rate of δex, an observed transition rate of δob, a true-positive percentage φTP, and 
false-positive percentage φFP we establish the following system: 1
FPTP
 and 
obTPTPex 3
1
 and can solve for specificity as 
ex
ob
TP
3
1
3
1
. We observe that this estimate is 
very consistent with the empirical specificity in known variants and novel variants based on 
experimental validation (Table 1). 
 We take expected ratios of 2.10 for known sites and 2.07 for novel sites from the GATK variant 
detection best-practices (http://www.broadinstitute.org/gsa), calculated as weighted averages across 
the 1000 Genomes CEU and YRI trios. 
For both variant types we then extrapolate the total expected number of variants in the standard way as 
expected = (observed) x (specificity) / (sensitivity). 
Figure Legends 
Figure 1: Imputation strategy and information capacity in founder population 
A: Schematic outline of the strategy. IBD shared haplotypes (color-coded) are identified from genotype data 
(grey spots) in a cohort; a small panel of individuals with abundance of IBD is sequenced (top); and sequenced 
variants within shared haplotypes are inferred to the rest of the cohort within shared regions (bottom). B: 
Percentage of genomic content of the cohort that is inferred (Total Information Potential) as a function of 
sequenced reference panel size, calculated from autosomal genotype data. Rapid growth of Total Information 
Potential in the highly-related Kosraen population (2,906 samples, green) compared to slower growth in less 
related Ashkenazi Jewish population (1,200 Crohn’s Disease case-control samples[27], brown). 
Figure 2: Population-specific genomewide allele frequency spectrum 
Variants previously observed in 1,000 Genomes Project pilot are plotted according to abundance in each 
sequenced genome (y-axis) as a function of allele frequency in the reference cohort (x-axis). Kosraen (“KOS”) 
genome compared to sequenced Korean (“SJK”); Yoruban (“YRI”); and European (“JCV”) genomes. Allele 
frequency spectrum measured in (A) East Asian - JPTCHB; (B) African - YRI; and (C) European - CEU origin 
reference cohorts. 
Figure 3: Frequency spectrum of putatively functional variants 
Histogram of variants annotated by their coding class and novelty. Each bar represents the percentage of 
variant sites (y-axis) at the respective allele frequency (x-axis) out of all observed in the respective variant 
class: (A) distribution of variants by functional class, showing significant enrichment for singleton nonsense 
mutations; (B) distribution of previously known (white) and novel (yellow) variants across the entire genome. 
Only sites where a call could be made in all samples are considered (total counts in Supplementary Table 1). 
Figure 4: Concordance of known and novel variants in IBD and non-IBD regions 
We examined concordance of called variants in previously predicted pairwise IBD regions. For all sites that are 
called homozygous in both samples with at least one being non-reference, we measure concordance (x-axis) 
as the percentage where both are non-reference. We expect 100% concordance in truly co-inherited regions 
with no sequence error. Y-axis shows percentage of IBD segments at a given concordance level. Concordance 
for previously known variants (A, white bar) and novel variants (B, yellow bar) is shown in comparison to 
randomly placed non-IBD regions of an equal length distribution (both, black points). On average, IBD 
segments maintained 99.6% (known) and 97.3% (novel) concordance compared 82.9% (known) and 31.0% 
(novel) in a background distribution of non-IBD segments. 
Supplementary Figure 1: Imputation capacity for genotype versus haplotype schemes 
Detailed breakdown of Total Information Potential as a function of sequencing budget for genotype-based 
(light blue) and haplotype-based (dark blue) inference; categorized according to random selection of samples 
(dashed line) and greedy optimization of sample selection (solid line). 
Supplementary Figure 2: Comparison of variants detected in published genomes 
Distribution of detected autosomal variants in previously published genomes shown compared to average 
Kosraen individual (“KOS (avg)” at left). Previously known variants (in dbSNP 130) shown in white bar and 
novel variants shown in yellow (extrapolation detailed in Materials & Methods). 
Supplementary Figure 3: Additional novel variants attained from further sequenced individuals 
Number of additional unique novel variant sites gained (y-axis) from each subsequent sequenced genome (x-
axis). Counts were measured across variant sites observed in any sample (grey  bar) and variant sites that 
could be called in all samples (yellow bar). The distribution represents an average across all unique 
permutations of the seven individuals. 
Supplementary Figure 4: Overall distribution of coding and general variants 
Each bar represents the percentage of variant sites (y-axis) at the respective allele frequency (x-axis) out of all 
sites observed in each variant class: all known (white), known coding (gray), all novel (yellow), novel coding 
(dark yellow). Only sites where a call could be made in all samples are considered (total counts in 
Supplementary Table 1). 
Supplementary Figure 5: Distribution of detected short insertions and deletions 
Histogram of novel (yellow) and previously known (white) indels across all seven individuals. Number of indels 
at each carrier level shown at cap of each bar. 
Supplementary Figure 6: Distribution of copy number variants detected 
Number and type of CNV identified in four sequenced individuals. Total number of discrete regions called (y-
axis) as function of CNV length (x-axis). 
Supplementary Figure 7: Sequence concordance as function of IBS segment length 
Concordance of sequenced homozygous variants in array-based IBS regions of increasing length. Previously 
known (black line) and novel (yellow line) variants shown on left y-axis as a function of segment length on x-
axis. Number of segments at each IBD length window shown in grey bars on right y-axis. 
Tables 
Table 1: Experimental validation of known and novel variants 
Call type 
Unique 
sites 
Observed 
Ti/Tv ratio 
Expected 
Ti/Tv ratio
1
 
Calculated 
variant 
specificity
2
 
Total calls 
validated 
Experimental 
variant 
specificity
3
 Sensitivity 
Known 4,522,474 2.07 2.10 98.9% 2,958,772 98.2%
4
 92.8%
4
 
Novel 1,212,831 1.74 2.07 88.6% 64 87.5% - 
 
1
From 1000 Genomes high-quality low-pass estimates. 
2
Calculated from difference in expected and observed Ti/Tv ratio (Materials & Methods). 
3
Percentage of non-reference calls experimentally validated as non-reference. 
4
Sensitivity/Specificity of calling SNPs of all seven samples together using GATK Unified Genotyper and imputation on combined low- 
coverage samples (Materials & Methods, Combined SNV calling). 
Supplementary Table 1: Read placement and coverage per sample 
Supplementary Table 2: Array-based quality control in filtered sequenced variants 
Supplementary Table 3: Experimental validation of called novel variants 
Supplementary Table 4: Called and extrapolated variants in seven Kosraen samples 
Supplementary Table 5: Putatively functional variants detected, called in all samples, and variant in a single 
sample 
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Supplementary Methods 
Preliminaries 
Terminology and Notation 
Identity by Descent (IBD). A pair of descendants of the same ancestor is IBD if they share haplotypes that have 
been transmitted along the respective lineages leading to them. The shared haplotypes lie on homologous 
chromosomes of different individuals or of the same individual, in the latter case the individual has related 
parents. Let P = {1, 2, …, n} be the set of all individuals belonging to the population under study. We denote by 
R(i,j) the collection of shared regions between individuals i, j ϵ  P. A shared region in R(i,j) is identified by a 
triplet (l,r,c), where l is its left endpoint, r right endpoint and c ϵ  C = {1, 2, …, 22} is the relevant chromosome. 
Total information Content. Our aim is to sequence only a subset of individuals to infer information about the 
unsequenced population. Total Information Content (TIC) of a set Q is the fraction of the cohort members’ 
genomes that we directly obtain or indirectly can infer by sequencing a subset of individuals. Formally, if each 
unsequenced individual i has regions of total length Li of her L-long genome inferred and Li(Q) as 
, then 
LP
i
Q
i
LLQ
QTIC
 
   . 
Utility of Sequencing an Individual. Given a set of already sequenced individuals Q, we associate each 
individual i  P\Q with it a quantity U(i,Q) that corresponds to the utility of sequencing i at this stage. U(i,Q) is 
the total length of regions that i shares with all unsequenced individuals across all chromosomes i.e. 
. 
Interval trees. Our method relies on an interval tree data structure. An interval tree is an ordered and self-
balancing tree data structure. We have an interval tree t(i,c) for each individual i and each chromosome c. 
Problem Definition 
We define the problem of Representative Selection as follows: 
Input:  The function R listing sets of shared regions for each pair of samples in population P  
Total budget b 
Output:  Set Q  P of b individuals to sequence such that TIC(Q) is maximized 
Our proposed methodology helps to determine which subset of individuals to sequence. The size of the subset is 
the sequencing budget b and the objective is to maximize TIC. This problem is reducible to the classic NP-hard 
optimization problem of Vertex Cover (VC): A special case where individuals either share the entire genome or 
nothing. Each vertex represents an individual and shared region of an individual on a particular chromosome. 
The edges represent the relatedness between regions. The problem then becomes that of picking a set of shared 
regions (individuals) such that we cover maximum number of edges. 
Algorithm 
Informal Outline 
We propose a greedy approach, selecting individuals one at a time, gradually admitting samples into the set Q. 
Error! Reference source not found. shows the formulation for this approach.  
 
Algorithm 1: Greedy Method for picking budget b number of individuals 
Data structure details 
Naive implementation of this greedy approach runs into the computational bottleneck of maintaining lists of shared 
regions for each pair of individuals. Intuitively, such regions keep getting shattered by interval exclusion operation in step 
2 of Error! Reference source not found.. Efficient implementation that maintains these intervals requires a special data 
structure. We use interval trees for this purpose. Each node in the tree contains an interval representing a shared region 
along with a pointer to the node in the tree of the other individual with whom the region is shared. The first step is to 
calculate U(i,Q), for each individual i ϵ  P\Q. Our greedy approach now selects the individual j with the highest value of 
U(i,Q). Before we make the next choice, we need to exclude regions that have been imputed by picking j. These are 
complete regions (l,r,c) in R(i,j), i  P which we will impute directly by sequencing individual j. Additionally, we will 
indirectly impute parts of regions (l’,r’,c’) in R(i,k), k  P\j that overlap with (l,r,c) in R(i,j). We then recalculate U(i,Q)  
i  P\j and make the next greedy choice followed by elimination of newly imputed segments. This continues till we have 
picked individuals up to our sequencing budget b. To understand this, consider a simple example. Suppose individuals A 
and B share region (5,20,1); B and C share (13,25,1) and A and C share (30,50,1). We see that U(A,Q) = 35, U(B,Q) = 27, 
U(C,Q) = 32. The greedy algorithm will first pick A and add it to Q. We exclude directly imputed regions (5,20,1) of 
R(A,B) and (30,50,1) of R(A,C). Also, the region (13,20,1) in R(B,C) has been indirectly imputed by picking A. The 
recalculated U(B,Q) = U(C,Q) = 5. 
Comparison to linked lists 
The individuals in one of the data sets we considered shared on an average thirteen million regions per 
chromosome. The magnitude of the dataset demands efficient management of these shared regions. Operations 
on regions like insertion into the interval tree, deletion, querying for overlaps (for finding intersection with 
imputed regions) and modifications need to be done quickly. Thus, a data structure was required that optimally 
scales to these large number of regions. One of the possible choices was a linked list. The linked list provides 
speed in terms of construction (O(n) time), insertion and deletion (O(1) time) of segments with linear and 
constant running times respectively. But the bottleneck was querying for overlaps (O(n) time for linked list) and 
subsequent modification of the regions, where majority of the running time was spent. In some cases the entire 
linked list may have to be traversed before an overlap is found and the worst case running time is linear in the 
number of shared regions. Thus, the linked list is not the best solution for this implementation. The interval tree 
data structure was a better alternative. Since a region is represented with a start and end point, it was suitable to 
be modeled as an interval or node of the tree. Moreover the worst case time to query for an overlap (see Fig. 3.) 
required O(log n + m) time, where the n refers to the total number of intervals in the tree and m refers to the 
number of overlapping intervals in the query. This improvement in running time is due to the balanced nature of 
the interval tree that made it possible to search in only a section of the tree to find the overlapping intervals. 
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Fig. 3. Representation of Interval Tree. Each node represents a shared region. The highlighted intervals are returned if we were to 
query for intervals overlapping (66,78,8).   
Formal Algorithm 
 
Algorithm 2: TREE-CREATION creates an interval tree for each individual i and each chromosome c and sets 
pointers between intervals shared by pairs of individuals. 
 
Algorithm 3: PICK-INDIVIDUAL picks individual j with the highest utility value and deletes intervals directly 
imputed by picking j. 
 Algorithm 4: SEGMENT-MODIFICATION eliminates parts of segments that are indirectly imputed by picking 
individual j. It first creates a list of individuals sharing segments with j, traverses their interval trees checking 
for three possible cases of overlaps and makes suitable modifications. 
Complexity 
To determine the complexity of the algorithm we need to take into account the two main operations; 
construction of the interval tree and querying for overlap. Construction of an interval tree requires O(n log n) 
time, where n represents the average number of shared regions per individual. Querying for overlap requires 
O(log n + m) time, with n being the total number of intervals in the interval tree and m being the number of 
overlapping intervals. Thus, the total complexity can be given as O(n log n + log n + m). The running time 
scales linearly in the number of shared regions. In terms of space complexity the interval tree requires O(n) 
space. 
Implementation 
The algorithm was implemented in C++ and is made available for download at 
http://www1.cs.columbia.edu/~itsik/INFOSTIP/readme.html. All experiments were conducted on Linux-based 
cluster controlled by Sun Grid Engine on a node with 16 GB memory. 
